Acorah Software Products - Accounts Production 16.5.460 false true false true No description of principal activity 23 October 2024 31 October 2025 31 October 2025 16036468 Dr Olufunke Abimbola iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 16036468 2024-10-22 16036468 2025-10-31 16036468 2024-10-23 2025-10-31 16036468 frs-core:CurrentFinancialInstruments 2025-10-31 16036468 frs-bus:PrivateLimitedCompanyLtd 2024-10-23 2025-10-31 16036468 frs-bus:FilletedAccounts 2024-10-23 2025-10-31 16036468 frs-bus:Micro-entities 2024-10-23 2025-10-31 16036468 frs-bus:AuditExempt-NoAccountantsReport 2024-10-23 2025-10-31 16036468 frs-bus:Director1 2024-10-23 2025-10-31
Registered number: 16036468
The Austen Bronte Consultancy Ltd
Unaudited Financial Statements
For the Period 23 October 2024 to 31 October 2025
Nasa Accountants Limited
5th Floor Blok
1 Castle Park
Bristol
BS2 0JA
Balance Sheet
Registered number: 16036468
31 October 2025
£
Current assets 16,361
Creditors: Amounts Falling Due Within One Year (13,357 )
NET CURRENT ASSETS 3,004
TOTAL ASSETS LESS CURRENT LIABILITIES 3,004
NET ASSETS 3,004
CAPITAL AND RESERVES 3,004

Notes

1. General Information
The Austen Bronte Consultancy Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 16036468 . The registered office is 3rd Floor, 86-90 Paul Street, London, EC2A 4NE.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Olufunke Abimbola
Director
28/11/2025